The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases-Reference-Cited by-同舟云学术

The Stem Cell Marker CD133 (Prominin-1) is Phosphorylated on Cytoplasmic Tyrosine-828 and Tyrosine-852 by Src and Fyn Tyrosine Kinases

Published:2009-04-06 Issue:18 Volume:48 Page:3998-4007
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Boivin Dominique¹,Labbé David¹,Fontaine Nicolas¹,Lamy Sylvie¹,Beaulieu Édith¹,Gingras Denis¹,Béliveau Richard¹²

Affiliation:

1. Laboratoire de Médecine Moléculaire, Chemistry Department, Université du Québec à Montréal, C.P. 8888, succ. centre-ville, Montréal, Québec, Canada H3C 3P8

2. Holder of the “Chaire en prévention et traitement du cancer” from Université du Québec à Montréal and of the Claude-Bertrand Chair in Neurosurgery from Université de Montréal

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi900159d

Reference42 articles.

1. CD133: molecule of the moment

2. Prominin: A Story of Cholesterol, Plasma Membrane Protrusions and Human Pathology

3. AC133/CD133/Prominin-1

4. Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?

5. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease;Cellular & Molecular Biology Letters;2024-03-26

2. CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance;Cells;2024-01-26

3. Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells;Cancers;2024-01-22

4. Pancreatic cancer stem cells and inflammation: milestones achieved and challenges ahead;Cancer Stem Cells and Signaling Pathways;2024

5. Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133;Cells;2023-03-06